Quick Takeaways
- Jami Rubin has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $338,900.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Jami Rubin
- Location
- Cambridge, MA
- Summary
- The estimated net worth of Jami Rubin is at least $338,900 dollars as of 06 Jun 2025. Jami Rubin is the Director of Relay Therapeutics, Inc. and owns shares of Relay Therapeutics, Inc. (RLAY) stock worth about $338.9K.
- Signature
- /s/ Brian Adams, as Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Jami Rubin and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Relay Therapeutics, Inc. ($338,900).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Jami Rubin
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| RLAY | Relay Therapeutics, Inc. | Director | $338,900 | 06 Jun 2025 | ||
| BOLD | Boundless Bio, Inc. | Chief Financial Officer | 19 Aug 2024 | |||
| EQRX | EQRx, Inc. | Chief Financial Officer | 01 Jan 2023 |
Insider Transactions Reported by Jami Rubin:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.